1. Home
  2. BDSX vs ACFN Comparison

BDSX vs ACFN Comparison

Compare BDSX & ACFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • ACFN
  • Stock Information
  • Founded
  • BDSX 2005
  • ACFN 1986
  • Country
  • BDSX United States
  • ACFN United States
  • Employees
  • BDSX N/A
  • ACFN N/A
  • Industry
  • BDSX Precision Instruments
  • ACFN Military/Government/Technical
  • Sector
  • BDSX Health Care
  • ACFN Consumer Discretionary
  • Exchange
  • BDSX Nasdaq
  • ACFN Nasdaq
  • Market Cap
  • BDSX 53.2M
  • ACFN 62.5M
  • IPO Year
  • BDSX 2020
  • ACFN N/A
  • Fundamental
  • Price
  • BDSX $0.43
  • ACFN $31.45
  • Analyst Decision
  • BDSX Strong Buy
  • ACFN
  • Analyst Count
  • BDSX 5
  • ACFN 0
  • Target Price
  • BDSX $1.75
  • ACFN N/A
  • AVG Volume (30 Days)
  • BDSX 4.2M
  • ACFN 28.8K
  • Earning Date
  • BDSX 10-31-2025
  • ACFN 11-06-2025
  • Dividend Yield
  • BDSX N/A
  • ACFN N/A
  • EPS Growth
  • BDSX N/A
  • ACFN 1520.82
  • EPS
  • BDSX N/A
  • ACFN 2.84
  • Revenue
  • BDSX $76,556,000.00
  • ACFN $13,202,000.00
  • Revenue This Year
  • BDSX $18.80
  • ACFN N/A
  • Revenue Next Year
  • BDSX $27.76
  • ACFN N/A
  • P/E Ratio
  • BDSX N/A
  • ACFN $9.74
  • Revenue Growth
  • BDSX 25.70
  • ACFN 50.98
  • 52 Week Low
  • BDSX $0.17
  • ACFN $17.22
  • 52 Week High
  • BDSX $1.88
  • ACFN $33.00
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 52.94
  • ACFN N/A
  • Support Level
  • BDSX $0.41
  • ACFN N/A
  • Resistance Level
  • BDSX $0.54
  • ACFN N/A
  • Average True Range (ATR)
  • BDSX 0.04
  • ACFN 0.00
  • MACD
  • BDSX -0.00
  • ACFN 0.00
  • Stochastic Oscillator
  • BDSX 30.90
  • ACFN 0.00

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About ACFN Acorn Energy Inc. Common Stock

Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.

Share on Social Networks: